Amyloid-lowering strategies may be most effective if administered prior to the clinical presentation of Alzheimer's disease. By the time memory trouble brings patients to see a physician, there may well already be brain pathology and nerve cell damage.
Glenn Caffery finally completed his 3,200 mile run across the U.S. on Wednesday, Aug. 17, on the shores of the Atlantic in Westerly, R.I. Caffery, a University of Massachusetts Amherst professor and veteran distance runner, began his Cure Alzheimer’s Run in Seaside, Ore., on May 19 to raise money and awareness for Alzheimer’s disease research and treatment.
Westerly, R.I.—After running more than 3,200 miles,University of Massachusetts Amherst professor and veteran distance runner Glenn Caffery is finally arriving at his destination of Westerly, R.I., on Aug. 17.
Alan Arnette has announced that he has summitted Mr. Elbrus in Russia.
Alan posted an audio dispatch this morning announcing the summit and said it took the team about 7.5 hours to get up to the West Summit. Mt. Elbrus is the fifth climb in The 7 Summits Climb for Alzheimer’s: Memories are Everything campaign.
Alan asks that people pledge a penny per foot for the climb, or about $100 for Elbrus, to go to Cure Alzheimer’s Fund, National Family Caregivers Association and the Alzheimer’s Association.
Dr. Sam Gandy, a Cure Alzheimer's Fund Consortium Research Member, was recently asked to comment on an Alzheimer's therapy study featured in the journal Nature. Dr. Gandy, an associate director at the Mount Sinai Alzheimer's Disease Research Center in New York, has been featured in Nature on numerous occasions for his knowledge and expertise in Alzheimer's disease research and treatment.